Healthcare provider profile · identity verified

Jillian Alfonso, MD

Family Practice · BRONX, NY · NPI 1629224159

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	684	214
Atorvastatin Calcium	Atorvastatin Calcium	676	201
Amlodipine Besylate	Amlodipine Besylate	572	161
Levothyroxine Sodium	Levothyroxine Sodium	474	106
Albuterol Sulfate Hfa	Albuterol Sulfate	408	110
Jardiance	Empagliflozin	339	85
Gabapentin	Gabapentin	327	89
Metoprolol Succinate	Metoprolol Succinate	308	80
Ozempic	Semaglutide	293	56
Lisinopril	Lisinopril	272	78
Famotidine	Famotidine	236	68
Nifedipine Er	Nifedipine	212	64
Hydrochlorothiazide	Hydrochlorothiazide	209	66
Furosemide	Furosemide	204	68
Metformin Hcl	Metformin Hcl	198	61
Omeprazole	Omeprazole	195	70
Losartan Potassium	Losartan Potassium	186	66
Glipizide Er	Glipizide	179	51
Meclizine Hcl	Meclizine Hcl	167	60
Linzess	Linaclotide	159	38
Simvastatin	Simvastatin	157	43
Montelukast Sodium	Montelukast Sodium	149	37
Allopurinol	Allopurinol	148	41
Metformin Hcl Er	Metformin Hcl	137	48
Fenofibrate	Fenofibrate,micronized	135	35
Meloxicam	Meloxicam	135	45
Pantoprazole Sodium	Pantoprazole Sodium	135	49
Ezetimibe	Ezetimibe	129	37
Hydralazine Hcl	Hydralazine Hcl	124	45
Eliquis	Apixaban	123	29
Fluticasone Propionate	Fluticasone Propionate	121	40
Glipizide	Glipizide	112	33
Baclofen	Baclofen	109	38
Tamsulosin Hcl	Tamsulosin Hcl	100	24
Carvedilol	Carvedilol	99	28
Metoprolol Tartrate	Metoprolol Tartrate	97	28
Ibuprofen	Ibuprofen	96	30
Glipizide-Metformin	Glipizide/Metformin Hcl	93	22
Farxiga	Dapagliflozin Propanediol	84	27
Januvia	Sitagliptin Phosphate	84	21
Indapamide	Indapamide	83	26
Trulicity	Dulaglutide	82	17
Candesartan Cilexetil	Candesartan Cilexetil	81	18
Ibandronate Sodium	Ibandronate Sodium	81	25
Single Use Swab	Alcohol Antiseptic Pads	79	29
Trazodone Hcl	Trazodone Hcl	79	26
Pravastatin Sodium	Pravastatin Sodium	78	19
Triamcinolone Acetonide	Triamcinolone Acetonide	77	26
Vascepa	Icosapent Ethyl	77	19
Rybelsus	Semaglutide	75	25
Diclofenac Sodium	Diclofenac Sodium	71	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	18
Alcohol Prep Pads	Alcohol Antiseptic Pads	69	27
Clopidogrel	Clopidogrel Bisulfate	65	19
Pioglitazone Hcl	Pioglitazone Hcl	64	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	17
Felodipine Er	Felodipine	59	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	58	14
Atenolol	Atenolol	56	15
Azithromycin	Azithromycin	56	53
Potassium Chloride	Potassium Chloride	55	25
Donepezil Hcl	Donepezil Hcl	54	22
Escitalopram Oxalate	Escitalopram Oxalate	54	19
Chlorthalidone	Chlorthalidone	53	18
Ammonium Lactate	Ammonium Lactate	52	26
Synthroid	Levothyroxine Sodium	51	16
Telmisartan	Telmisartan	51	15
Mounjaro	Tirzepatide	49	11
Naproxen	Naproxen	49	14
Lidocaine	Lidocaine	47	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	46	19
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	46	18
Novolog Flexpen	Insulin Aspart	45	15
Enalapril Maleate	Enalapril Maleate	44	suppressed
Irbesartan	Irbesartan	44	suppressed
Prednisone	Prednisone	44	37
Vitamin D2	Ergocalciferol (Vitamin D2)	43	32
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	41	13
Spironolactone	Spironolactone	41	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	18
Janumet Xr	Sitagliptin Phos/Metformin Hcl	40	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	39	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	11
Warfarin Sodium	Warfarin Sodium	38	suppressed
Clobetasol Propionate	Clobetasol Propionate	36	16
Memantine Hcl	Memantine Hcl	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	12
Azelastine Hcl	Azelastine Hcl	34	12
Myrbetriq	Mirabegron	34	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	31
Sertraline Hcl	Sertraline Hcl	32	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Ketoconazole	Ketoconazole	30	11
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	30	23
Topiramate	Topiramate	30	suppressed
Fluconazole	Fluconazole	29	20
Tresiba Flextouch U-100	Insulin Degludec	29	11
Valacyclovir	Valacyclovir Hcl	29	15
True Comfort Pro Alcohol Pads	Alcohol Antiseptic Pads	28	11
Finasteride	Finasteride	27	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	24
Xarelto	Rivaroxaban	26	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	25	suppressed
Loperamide	Loperamide Hcl	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	12
Fluocinonide	Fluocinonide	23	suppressed
Mometasone Furoate	Mometasone Furoate	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Colchicine	Colchicine	22	suppressed
Folic Acid	Folic Acid	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Amoxicillin	Amoxicillin	20	20
Calcitriol	Calcitriol	20	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Ciclopirox	Ciclopirox Olamine	18	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Valsartan	Valsartan	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Fosinopril Sodium	Fosinopril Sodium	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Cefdinir	Cefdinir	14	14
Halobetasol Propionate	Halobetasol Propionate	14	suppressed
Methimazole	Methimazole	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Mirtazapine	Mirtazapine	14	suppressed
Nystatin	Nystatin	14	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	14	suppressed
Wegovy	Semaglutide	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Famciclovir	Famciclovir	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Restasis	Cyclosporine	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error